Variant report
Variant | rs34756253 |
---|---|
Chromosome Location | chr3:50567007-50567008 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:50566678..50573015-chr3:50574866..50578180,7 | K562 | blood: | |
2 | chr3:50564906..50567143-chr3:50571268..50573066,2 | MCF-7 | breast: | |
3 | chr3:50560226..50564542-chr3:50564835..50568102,5 | K562 | blood: | |
4 | chr3:50561864..50565057-chr3:50565315..50568645,4 | K562 | blood: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs1034405 | 0.93[EUR][1000 genomes] |
rs11130252 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs11130255 | 1.00[AFR][1000 genomes] |
rs11719998 | 0.90[EUR][1000 genomes] |
rs12491425 | 0.89[EUR][1000 genomes] |
rs12493985 | 0.84[EUR][1000 genomes] |
rs129310 | 0.83[EUR][1000 genomes] |
rs13065995 | 0.88[AFR][1000 genomes] |
rs13075344 | 1.00[AFR][1000 genomes] |
rs13075377 | 0.88[AFR][1000 genomes] |
rs13076850 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs13083004 | 0.87[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs13084476 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs13084771 | 1.00[AFR][1000 genomes] |
rs13085096 | 1.00[AFR][1000 genomes] |
rs13089719 | 1.00[AFR][1000 genomes] |
rs13091933 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs13094336 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs13095920 | 1.00[AFR][1000 genomes] |
rs13096264 | 0.94[AFR][1000 genomes] |
rs13096268 | 0.88[AFR][1000 genomes] |
rs13096772 | 1.00[AFR][1000 genomes] |
rs1458386 | 1.00[AFR][1000 genomes] |
rs1458387 | 1.00[AFR][1000 genomes] |
rs1463496 | 0.84[AFR][1000 genomes] |
rs1463497 | 1.00[AFR][1000 genomes] |
rs1563683 | 1.00[AFR][1000 genomes] |
rs175634 | 0.82[EUR][1000 genomes] |
rs17660179 | 0.88[AFR][1000 genomes] |
rs17660513 | 0.88[AFR][1000 genomes] |
rs17787569 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs1824280 | 1.00[AFR][1000 genomes] |
rs1902960 | 1.00[AFR][1000 genomes] |
rs1947607 | 0.88[AFR][1000 genomes] |
rs1966920 | 0.88[AFR][1000 genomes] |
rs1975834 | 0.89[AFR][1000 genomes] |
rs201194 | 0.90[EUR][1000 genomes] |
rs201196 | 0.93[EUR][1000 genomes] |
rs201197 | 0.82[EUR][1000 genomes] |
rs201198 | 0.93[EUR][1000 genomes] |
rs2061388 | 0.88[AFR][1000 genomes] |
rs2085587 | 0.88[AFR][1000 genomes] |
rs2125366 | 1.00[AFR][1000 genomes] |
rs2125369 | 1.00[AFR][1000 genomes] |
rs2168863 | 0.88[AFR][1000 genomes] |
rs2168866 | 1.00[AFR][1000 genomes] |
rs2199050 | 0.88[AFR][1000 genomes] |
rs2227280 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2232248 | 0.85[EUR][1000 genomes] |
rs2232253 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2262810 | 0.88[AFR][1000 genomes] |
rs2269507 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2355321 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2355323 | 0.84[EUR][1000 genomes] |
rs2355341 | 1.00[AFR][1000 genomes] |
rs2355696 | 0.88[AFR][1000 genomes] |
rs2608989 | 1.00[AFR][1000 genomes] |
rs2608993 | 0.88[AFR][1000 genomes] |
rs2608997 | 0.88[AFR][1000 genomes] |
rs2608999 | 0.88[AFR][1000 genomes] |
rs2609001 | 0.88[AFR][1000 genomes] |
rs2609005 | 0.88[AFR][1000 genomes] |
rs2609006 | 0.88[AFR][1000 genomes] |
rs2609020 | 0.88[AFR][1000 genomes] |
rs2609021 | 0.88[AFR][1000 genomes] |
rs2609022 | 0.88[AFR][1000 genomes] |
rs2609024 | 1.00[AFR][1000 genomes] |
rs2609025 | 1.00[AFR][1000 genomes] |
rs2609035 | 1.00[AFR][1000 genomes] |
rs2609036 | 1.00[AFR][1000 genomes] |
rs2609037 | 0.88[AFR][1000 genomes] |
rs2675769 | 1.00[AFR][1000 genomes] |
rs2675772 | 1.00[AFR][1000 genomes] |
rs2675773 | 1.00[AFR][1000 genomes] |
rs2675774 | 1.00[AFR][1000 genomes] |
rs2675787 | 0.88[AFR][1000 genomes] |
rs2675788 | 0.88[AFR][1000 genomes] |
rs2675789 | 0.88[AFR][1000 genomes] |
rs2675790 | 0.88[AFR][1000 genomes] |
rs2675791 | 0.88[AFR][1000 genomes] |
rs2675792 | 0.88[AFR][1000 genomes] |
rs2675793 | 0.88[AFR][1000 genomes] |
rs2675794 | 0.88[AFR][1000 genomes] |
rs2675799 | 0.82[AFR][1000 genomes] |
rs2675800 | 0.88[AFR][1000 genomes] |
rs2675802 | 1.00[AFR][1000 genomes] |
rs2675806 | 0.88[AFR][1000 genomes] |
rs2675809 | 1.00[AFR][1000 genomes] |
rs2675810 | 1.00[AFR][1000 genomes] |
rs2675812 | 0.88[AFR][1000 genomes] |
rs2675813 | 0.88[AFR][1000 genomes] |
rs2675827 | 0.88[AFR][1000 genomes] |
rs2675828 | 0.88[AFR][1000 genomes] |
rs2675829 | 0.88[AFR][1000 genomes] |
rs2675830 | 0.88[AFR][1000 genomes] |
rs2675832 | 0.88[AFR][1000 genomes] |
rs2675834 | 0.88[AFR][1000 genomes] |
rs2675835 | 0.82[AFR][1000 genomes] |
rs2675836 | 0.88[AFR][1000 genomes] |
rs2675837 | 0.88[AFR][1000 genomes] |
rs3101107 | 0.88[AFR][1000 genomes] |
rs3106826 | 0.88[AFR][1000 genomes] |
rs34048522 | 0.88[AFR][1000 genomes] |
rs34202063 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs34266990 | 1.00[AFR][1000 genomes] |
rs34267788 | 0.96[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs34320663 | 0.88[AFR][1000 genomes] |
rs34390947 | 1.00[AFR][1000 genomes] |
rs34399912 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs34434811 | 0.81[AMR][1000 genomes];0.96[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs34492910 | 0.89[AFR][1000 genomes] |
rs34576538 | 0.88[AFR][1000 genomes] |
rs34584636 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs34632971 | 1.00[AFR][1000 genomes] |
rs34773360 | 1.00[AFR][1000 genomes] |
rs34846525 | 1.00[AFR][1000 genomes] |
rs34866096 | 1.00[AFR][1000 genomes] |
rs34889917 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs35098074 | 0.88[AFR][1000 genomes] |
rs35140911 | 1.00[AFR][1000 genomes] |
rs35170043 | 1.00[AFR][1000 genomes] |
rs35429015 | 1.00[AFR][1000 genomes] |
rs35531616 | 1.00[AFR][1000 genomes] |
rs35566897 | 1.00[AFR][1000 genomes] |
rs35655236 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs35690191 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs35714264 | 0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs35864641 | 0.81[AMR][1000 genomes];0.96[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs35908181 | 0.85[ASN][1000 genomes] |
rs36011798 | 0.89[AFR][1000 genomes] |
rs3804627 | 0.84[EUR][1000 genomes] |
rs3804628 | 1.00[AFR][1000 genomes] |
rs391620 | 0.90[EUR][1000 genomes] |
rs3940822 | 0.88[AFR][1000 genomes] |
rs398703 | 0.89[EUR][1000 genomes] |
rs399484 | 0.90[EUR][1000 genomes] |
rs399971 | 0.82[EUR][1000 genomes] |
rs417592 | 0.84[EUR][1000 genomes] |
rs441516 | 0.84[EUR][1000 genomes] |
rs4429624 | 1.00[AFR][1000 genomes] |
rs443030 | 0.83[EUR][1000 genomes] |
rs4533647 | 0.81[AMR][1000 genomes];0.96[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs453570 | 0.84[EUR][1000 genomes] |
rs4688702 | 0.89[AFR][1000 genomes] |
rs4688703 | 1.00[AFR][1000 genomes] |
rs4688712 | 0.81[EUR][1000 genomes] |
rs490634 | 0.89[EUR][1000 genomes] |
rs5000953 | 1.00[AFR][1000 genomes] |
rs59909173 | 0.94[AFR][1000 genomes] |
rs59949730 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs61142614 | 0.87[AFR][1000 genomes] |
rs61549968 | 1.00[AFR][1000 genomes] |
rs622502 | 0.81[EUR][1000 genomes] |
rs628081 | 0.85[EUR][1000 genomes] |
rs6446215 | 1.00[AFR][1000 genomes] |
rs66867590 | 1.00[AFR][1000 genomes] |
rs67316637 | 0.88[AFR][1000 genomes] |
rs67410403 | 0.88[AFR][1000 genomes] |
rs67425923 | 0.90[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs67588094 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs6768300 | 0.80[EUR][1000 genomes] |
rs6775012 | 1.00[AFR][1000 genomes] |
rs67813889 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs6784166 | 0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6787521 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs6791880 | 1.00[AFR][1000 genomes] |
rs68191286 | 1.00[AFR][1000 genomes] |
rs695170 | 0.84[EUR][1000 genomes] |
rs71326937 | 0.84[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs71326944 | 1.00[AFR][1000 genomes] |
rs71326945 | 0.94[AFR][1000 genomes] |
rs71329007 | 0.88[AFR][1000 genomes] |
rs71329008 | 0.82[AFR][1000 genomes] |
rs73072418 | 1.00[AFR][1000 genomes] |
rs73072438 | 1.00[AFR][1000 genomes] |
rs73072442 | 1.00[AFR][1000 genomes] |
rs73082948 | 0.94[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs73833888 | 0.88[AFR][1000 genomes] |
rs73835540 | 0.94[AFR][1000 genomes] |
rs750453 | 0.90[EUR][1000 genomes] |
rs750510 | 0.84[EUR][1000 genomes] |
rs7629253 | 1.00[AFR][1000 genomes] |
rs7646236 | 0.84[EUR][1000 genomes] |
rs7650574 | 1.00[AFR][1000 genomes] |
rs7652260 | 0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs809451 | 0.81[EUR][1000 genomes] |
rs809454 | 0.80[EUR][1000 genomes] |
rs936405 | 1.00[AFR][1000 genomes] |
rs936406 | 1.00[AFR][1000 genomes] |
rs9830920 | 0.86[EUR][1000 genomes] |
rs9839684 | 1.00[AFR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv523662 | chr3:50144951-50584999 | Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 101 gene(s) | inside rSNPs | diseases |
2 | esv1821728 | chr3:50156142-50657253 | Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 109 gene(s) | inside rSNPs | diseases |
3 | nsv470561 | chr3:50158774-50584999 | Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 99 gene(s) | inside rSNPs | diseases |
4 | nsv876770 | chr3:50158774-50609624 | Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 103 gene(s) | inside rSNPs | diseases |
5 | nsv1001993 | chr3:50187646-50640808 | Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 104 gene(s) | inside rSNPs | diseases |
6 | esv3584502 | chr3:50368278-50659741 | Strong transcription Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
7 | nsv432419 | chr3:50388396-50637496 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
8 | nsv1013225 | chr3:50440826-50700448 | Flanking Active TSS Enhancers Genic enhancers Weak transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
9 | nsv536566 | chr3:50440826-50700448 | Genic enhancers Weak transcription Flanking Active TSS Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
10 | nsv984540 | chr3:50473691-50669310 | Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 28 gene(s) | inside rSNPs | diseases |
11 | nsv1012501 | chr3:50483037-50679591 | Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
12 | nsv536567 | chr3:50483037-50679591 | Bivalent Enhancer Strong transcription Flanking Active TSS Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
13 | nsv460532 | chr3:50536273-50616049 | Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
14 | nsv590272 | chr3:50536273-50616049 | Weak transcription Enhancers Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:50558800-50570600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr3:50561400-50567200 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr3:50564000-50567200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr3:50564400-50567200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr3:50565000-50567400 | Weak transcription | Brain Germinal Matrix | brain |
6 | chr3:50566800-50567200 | Weak transcription | Spleen | Spleen |
7 | chr3:50566800-50568800 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
8 | chr3:50566800-50569200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
9 | chr3:50567000-50567600 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
10 | chr3:50567000-50568000 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
11 | chr3:50567000-50568800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |